-
Domain structure of vaccinia DNA ligase.
Molecular Biology Program, Sloan-Kettering Institute, New York 10021, USA.
The 552 amino acid vaccinia virus DNA ligase consists of three structural domains defined by partial proteolysis: (i) an amino-terminal 175 amino acid segment that is susceptible to digestion with chymotrypsin and trypsin; (ii) a protease-resistant central domain that contains the active site of nucleotidyl transfer (Lys-231); (iii) a protease-resistant carboxyl domain. The two protease-resistant domains are separated by a protease-sensitive interdomain bridge from positions 296 to 307. Adenylyltransferase and DNA ligation activities are preserved when the N-terminal 200 amino acids are deleted. However, the truncated form of vaccinia ligase has a reduced catalytic rate in strand joining and a lower affinity for DNA than does the full-sized enzyme. The 350 amino acid catalytic core of the vaccinia ligase is similar in size and protease-sensitivity to the full-length bacteriophage T7 DNA ligase.
PMID: 9016621 [PubMed - indexed for MEDLINE]
PMCID: PMC146513
-
Cited by 10 PubMed Central articles
-
Vaccinia virus DNA ligase recruits cellular topoisomerase II to sites of viral replication and assembly.
Lin YC, Li J, Irwin CR, Jenkins H, DeLange L, Evans DH.
J Virol. 2008 Jun; 82(12):5922-32. Epub 2008 Apr 16.
[J Virol. 2008]
-
Two DNA-binding and nick recognition modules in human DNA ligase III.
Cotner-Gohara E, Kim IK, Tomkinson AE, Ellenberger T.
J Biol Chem. 2008 Apr 18; 283(16):10764-72. Epub 2008 Jan 30.
[J Biol Chem. 2008]
-
Identification of novel antipoxviral agents: mitoxantrone inhibits vaccinia virus replication by blocking virion assembly.
Deng L, Dai P, Ciro A, Smee DF, Djaballah H, Shuman S.
J Virol. 2007 Dec; 81(24):13392-402. Epub 2007 Oct 10.
[J Virol. 2007]
- » See all...